Inhibition of ABCB1 overcomes cancer stem cell-like properties and acquired resistance to MET inhibitor in non-small cell lung cancer

被引：0
|
作者：
Sugano, Teppei [1 ]
Seike, Masahiro [1 ]
Noro, Rintaro [1 ]
Soeno, Chie [1 ]
Nakamichi, Shinji [1 ]
Nishijima, Nobuhiko [1 ]
Matsumoto, Masaru [1 ]
Takeuchi, Susumu [1 ]
Miyanaga, Akihiko [1 ]
Kubota, Kaoru [1 ]
Gemma, Akihiko [1 ]
机构：
[1] Nippon Med Sch, Grad Sch Med, Dept Pulm Med & Oncol, Tokyo 113, Japan
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-756
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
756
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
    Alejandro Herreros-Pomares
    Juan Diego de-Maya-Girones
    Silvia Calabuig-Fariñas
    Rut Lucas
    Alicia Martínez
    José Miguel Pardo-Sánchez
    Sergio Alonso
    Ana Blasco
    Ricardo Guijarro
    Miguel Martorell
    Eva Escorihuela
    María Dolores Chiara
    Elena Duréndez
    Carolina Gandía
    Jerónimo Forteza
    Rafael Sirera
    Eloísa Jantus-Lewintre
    Rosa Farràs
    Carlos Camps
    Cell Death & Disease, 10
  • [42] Addition of S-1 to the Epidermal Growth Factor Receptor Inhibitor Gefitinib Overcomes Gefitinib Resistance in Non-small cell Lung Cancer Cell Lines with MET Amplification
    Okabe, Takafumi
    Okamoto, Isamu
    Tsukioka, Sayaka
    Uchida, Junji
    Hatashita, Erina
    Yamada, Yuki
    Yoshida, Takeshi
    Nishio, Kazuto
    Fukuoka, Masahiro
    Jaenne, Pasi A.
    Nakagawa, Kazuhiko
    CLINICAL CANCER RESEARCH, 2009, 15 (03) : 907 - 913
  • [43] MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer
    Ruan, Ji
    ASIA-PACIFIC JOURNAL OF ONCOLOGY NURSING, 2021, 8 (06) : 594 - 595
  • [44] TROY Modulates Cancer Stem-Like Cell Properties and Gefitinib Resistance Through EMT Signaling in Non-Small Cell Lung Cancer
    Wu, Linying
    Yu, Yuman
    Xu, Liming
    Wang, Xiaoling
    Zhou, Jianying
    Wang, Yuehong
    FRONTIERS IN GENETICS, 2022, 13
  • [45] Combination of quinacrine and erlotinib overcomes resistance to erlotinib in non-small cell lung cancer
    Dermavvan, Josephine Kam Tai
    Gurova, Katerina
    Pink, John
    Dowlati, Afshin
    De, Sarmishtha
    Naria, Goutham
    Sharma, Neelesh
    Stark, George
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [46] Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
    Yeung, Yiu To
    Yin, Shuying
    Lu, Bingbing
    Fan, Suyu
    Yang, Ran
    Bai, Ruihua
    Zhang, Chengjuan
    Bode, Ann M.
    Liu, Kangdong
    Dong, Zigang
    EBIOMEDICINE, 2018, 28 : 51 - 61
  • [47] MNK/eIF4E inhibition overcomes anlotinib resistance in non-small cell lung cancer
    Zhang, Qi
    Li, Hui
    Li, Quan
    Hu, Qiyan
    Liu, Bo
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 (02) : 245 - 252
  • [48] Resistance to KRAS inhibition in advanced non-small cell lung cancer
    Sreter, Katherina Bernadette
    Catarata, Maria Joana
    von Laffert, Maximilian
    Frille, Armin
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [49] AXL inhibition overcomes erlotinib resistance in AXL-activated non-small cell lung cancer cells
    Wang, Feng
    CANCER RESEARCH, 2018, 78 (13)
  • [50] Inhibition of osteopontin overcomes acquired resistance to afatinib in EGFR-mutant non-small-cell lung cancer
    Zhang, Hongye
    Wang, Ruiyu
    Wang, Mingxia
    Luo, Judong
    Liu, Changmin
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (02) : 754 - 762
12345